Molecular Biomedicine

杂志介绍

Molecular Biomedicine杂志介绍

《Molecular Biomedicine》是一本以English为主的开放获取国际优秀期刊，中文名称分子生物医学，本刊主要出版、报道医学-BIOCHEMISTRY & MOLECULAR BIOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为6.3，最新CiteScore 指数为6.3。

英文介绍

Molecular Biomedicine杂志英文介绍

Molecular Biomedicine, launched in 2020, is a peer-reviewed, open access journal published annually. It is a collaborative venture between the globally renowned scientific publishing company Springer Nature and the Sichuan Association for the Promotion of International Medical Exchange. This journal is dedicated to publishing high-quality research in the field of biomedicine from a molecular perspective, encompassing both fundamental and clinical studies.

Focusing on the mechanisms of human disease, as well as advancements in prevention, diagnosis, and treatment, Molecular Biomedicine aims to become a leading international academic journal with a significant impact in the biomedicine sector. The journal's commitment to open access ensures that its content is widely accessible, fostering global exchange of scientific knowledge and accelerating the dissemination of breakthroughs in molecular medicine.By embracing innovative research methodologies and interdisciplinary approaches, Molecular Biomedicine is positioned to contribute to the advancement of medical science, offering insights that could potentially lead to improved healthcare outcomes. The journal's editorial board, composed of experts from around the world, ensures that the published work meets the highest standards of scientific rigor and integrity, solidifying its reputation as a trusted source of information in the scientific community.